Best Peptides for Gut Health

Gut-healing peptides target specific mechanisms of GI damage and repair:

• Mucosal repair: Stimulating epithelial cell growth and tight junction restoration
• Anti-inflammation: Reducing inflammatory cytokines in gut tissue
• Tight junction regulation: Restoring the intestinal barrier that prevents "leaky gut"
• Angiogenesis: Building new blood vessels to support gut tissue healing
• Microbiome support: Reducing inflammation creates a better environment for beneficial bacteria

BPC-157 (Body Protection Compound) is derived from a protein found in human gastric juice — making it uniquely suited for GI healing.

Mechanism: BPC-157 promotes gut mucosal healing, restores tight junctions, reduces inflammation through NO system modulation, enhances angiogenesis in damaged gut tissue, and has been shown to heal ulcers, fistulas, and inflammatory bowel lesions in research models.

Dosage Range: Oral: 250–500 mcg/day (capsules or reconstituted in water, taken on empty stomach). Injectable: 250–500 mcg/day subcutaneously. Oral administration is preferred for GI-specific healing.

Research Evidence: Extensive studies show BPC-157 heals gastric ulcers, esophageal damage, intestinal anastomosis, inflammatory bowel lesions, and fistulas. It has also shown protective effects against NSAID-induced gut damage.

Pros:

• Oral administration available — no injections needed for gut healing
• Derived from natural gastric protective protein
• Heals virtually all types of GI damage
• Protects against future damage (NSAID gastroprotection)

Cons:

• Animal study evidence primarily
• Oral bioavailability may vary between individuals
• Stability of oral preparations varies by quality

KPV is a C-terminal tripeptide of alpha-MSH with potent anti-inflammatory effects specifically beneficial for inflammatory bowel conditions.

Mechanism: KPV inhibits NF-κB inflammatory signaling, reduces pro-inflammatory cytokines (TNF-α, IL-6, IL-1β), and has been shown to cross epithelial cells to reach inflammatory sites in the gut. It acts as a targeted anti-inflammatory without immunosuppression.

Dosage Range: Oral: 200–500 mcg/day. Injectable: 200–500 mcg/day subcutaneously. Oral formulations are preferred for gut-specific effects.

Research Evidence: Studies in colitis models show KPV significantly reduces inflammation, prevents tissue damage, and promotes mucosal healing. It demonstrated efficacy comparable to conventional anti-inflammatory treatments.

Pros:

• Specifically targets gut inflammation
• Small size allows oral absorption
• Anti-inflammatory without immunosuppression

Cons:

• Newer compound with less extensive research
• Limited human trial data
• Best used alongside a healing peptide like BPC-157

Larazotide acetate is a peptide specifically designed to restore tight junction integrity — directly addressing "leaky gut" at the structural level.

Mechanism: Larazotide regulates zonulin pathways that control intestinal permeability. By tightening the junctions between epithelial cells, it prevents unwanted molecules from crossing the gut barrier into the bloodstream.

Dosage Range: Oral: 0.5–1 mg three times daily in clinical trials.

Research Evidence: Phase III clinical trials for celiac disease showed larazotide significantly reduced GI symptoms and intestinal permeability. It's the most advanced tight-junction-targeted peptide in clinical development.

Pros:

• Directly addresses leaky gut mechanism
• Most advanced clinical trial data for gut barrier peptides
• Oral administration

Cons:

• Narrow mechanism — best combined with broader healing peptides
• Currently in clinical development (limited availability)
• Studied primarily for celiac — less data for other conditions

Gut healing peptides, especially oral formulations, require exceptional purity. Ascension Peptides is our recommendation:

• 99%+ purity on BPC-157 and KPV
• Third-party tested with COAs for every batch
• Fast US shipping for quick access to healing support
• Proper lyophilization ensures stability for reconstitution